Skip to content

Percuflex™ Plus M0061752830Recalls & reported problems

Boston Scientific Corporation · Ureteral Stent · Class 2 · Implant

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 08714729041221), received between May 17, 2021 and May 17, 2021 — classified as 1 injury.

The most frequently reported specific device problem is “Use of Device Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Use of Device Problem1

Patient problems

  • Sepsis1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryMay 17, 2021Use of Device Problem; Use of Device Problem

    IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION THAT A PERCUFLEX PLUS URETERAL STENT WAS USED DURING A LASER LITHOTRIPSY PROCEDURE, PERFORMED ON (B)(6) 2021. SHORTLY POST PROCEDURE, THE PHYSICIAN NOTICED THAT THE IMPLANTED STENT WAS EXPIRED. THE PHYSICIAN DECIDED TO LEAVE THE STENT IMPLANTED. THE PATIENT BECAME SEPTIC WITHIN THE SAME AND THE IMPLANTED STENT WAS SUCCESSFULLY REMOVED ON THE SAME DAY.

    Patient problems: Sepsis

    MAUDE report 11834948 ↗

Other STENT, URETERAL devices

All STENT, URETERAL devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page